Verrica Pharmaceuticals Inc. (VRCA)
NASDAQ: VRCA · Real-Time Price · USD
5.45
-0.35 (-6.03%)
At close: Mar 20, 2026, 4:00 PM EDT
5.56
+0.11 (2.02%)
After-hours: Mar 20, 2026, 4:56 PM EDT
Verrica Pharmaceuticals Employees
Verrica Pharmaceuticals had 76 employees as of December 31, 2025. The number of employees increased by 5 or 7.04% compared to the previous year.
Employees
76
Change (1Y)
5
Growth (1Y)
7.04%
Revenue / Employee
$468,118
Profits / Employee
-$235,342
Market Cap
93.62M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 76 | 5 | 7.04% |
| Dec 31, 2024 | 71 | -29 | -29.00% |
| Dec 31, 2023 | 100 | 78 | 354.55% |
| Dec 31, 2022 | 22 | -16 | -42.11% |
| Dec 31, 2021 | 38 | 9 | 31.03% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Gossamer Bio | 162 |
| Seer, Inc. | 124 |
| Fortress Biotech | 101 |
| Pyxis Oncology | 44 |
| Cognition Therapeutics | 28 |
| Q32 Bio | 26 |
| TuHURA Biosciences | 19 |
| Dogwood Therapeutics | 12 |
VRCA News
- 1 day ago - VRCA Investors Have the Opportunity to Join Investigation of Verrica Pharmaceuticals Inc. with the Schall Law Firm - Business Wire
- 2 days ago - VRCA Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Verrica Pharmaceuticals Inc. – VRCA - Business Wire
- 3 days ago - Verrica Pharmaceuticals Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Verrica Pharmaceuticals Inc. – VRCA - Business Wire
- 11 days ago - Verrica Pharmaceuticals Inc. (VRCA) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 11 days ago - Verrica Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results - GlobeNewsWire
- 17 days ago - Verrica Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results and Provide a Corporate Update on March 11, 2026 - GlobeNewsWire
- 27 days ago - Verrica Pharmaceuticals to Participate in the TD Cowen 46th Annual Health Care Conference - GlobeNewsWire
- 5 weeks ago - Verrica Pharmaceuticals Appoints Chris Chapman as Chief Commercial Officer - GlobeNewsWire